Universidad Nacional de Colombia, Bogotá, Colombia; Clínica Colsanitas, Bogotá, Colombia.
Instituto de Evaluación Tecnológica en Salud, Bogotá, Colombia.
Travel Med Infect Dis. 2023 May-Jun;53:102594. doi: 10.1016/j.tmaid.2023.102594. Epub 2023 May 19.
Colombia is the fifth most affected country by the global monkeypox outbreak and the second in LAC after Brazil. We describe the clinical and epidemiological characteristics of 521 patients with mpox in the country.
We conducted an observational analysis of laboratory-confirmed Mpox cases between June 29 and November 16, 2022.
Most cases were young men living with HIV. The clinical evolution was primarily benign, with two deaths reported. We found some differences between women and men regarding their BMI, presence of lymphadenopathies, localization of lesions, and the antecedent of HIV infection.
Although it seems that the epidemic curve for this outbreak of Mpox is decreasing not only in Colombia but globally, it could remain endemic. Therefore, it is necessary to maintain very close surveillance.
哥伦比亚是受全球猴痘疫情影响第五大的国家，也是继巴西之后拉丁美洲的第二大国家。我们描述了该国 521 例猴痘患者的临床和流行病学特征。
我们对 2022 年 6 月 29 日至 11 月 16 日期间实验室确诊的猴痘病例进行了观察性分析。
大多数病例是与 HIV 共感染的年轻男性。临床演变主要是良性的，报告了两例死亡。我们发现，女性和男性在 BMI、淋巴结病、病变定位和 HIV 感染史方面存在一些差异。
尽管看起来不仅在哥伦比亚，而且在全球范围内，猴痘疫情的流行曲线正在下降，但它仍可能成为地方性疾病。因此，有必要进行非常密切的监测。
